BioCentury
ARTICLE | Company News

Repros board of directors update

October 6, 2008 7:00 AM UTC

Repros Therapeutics Inc. (NASDAQ:RPRX), The Woodlands, Texas Business: Genitourinary, Endocrine Appointed: Mark Lappe, managing partner at Efficacy Capital Ltd.; and John Reed, president and CEO of th...